1-3 of 3
Niroshan Nadarajah
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing

Anna Maierhofer, Nikita Mehta, Ryan A. Chisholm, Stephan Hutter, Constance Baer, Niroshan Nadarajah, Christian Pohlkamp, Ella R. Thompson, Paul A. James, Wolfgang Kern, Claudia Haferlach, Manja Meggendorfer, Torsten Haferlach, Piers Blombery
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7346–7357.
https://doi.org/10.1182/bloodadvances.2023011389
Published: 2023
Includes: Supplemental data
Journal Articles

Interplay of TP53 allelic state, blast count, and complex karyotype on survival of patients with AML and MDS

Anna Stengel, Manja Meggendorfer, Wencke Walter, Constance Baer, Niroshan Nadarajah, Stephan Hutter, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5540–5548.
https://doi.org/10.1182/bloodadvances.2023010312
Published: 2023
Journal Articles

NPM1 mutated AML can relapse with wild-type NPM1 : persistent clonal hematopoiesis can drive relapse

Clinical Trials & Observations
Alexander Höllein, Manja Meggendorfer, Frank Dicker, Sabine Jeromin, Niroshan Nadarajah, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach
Journal: Blood Advances
Blood Adv (2018) 2 (22): 3118–3125.
https://doi.org/10.1182/bloodadvances.2018023432
Published: 2018